Insulet PODD
NASDAQ PODD
$134.96 -2.96 (-2.14%)
As of: Sep 10, 2026 · 2:51 PM EDT

Insulet (PODD) Net Cash Flow (2010 - 2026)

Insulet's (PODD) quarterly Net Cash Flow came in at $55.0 million in Q2 2026, up 132.3% on a YoY basis from $23.7 million in Q2 2025, and up 123.52% quarter-over-quarter from -$233.8 million in Q1 2026.

Analysis

Insulet (PODD) Net Cash Flow (2010 - 2026) Analysis & Trends

Insulet (PODD) has reported Net Cash Flow for 17 consecutive years, with $55.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Cash Flow rose 132.3% year-over-year to $55.0 million; the trailing twelve-month figure through Jun 2026 stood at -$583.1 million (down 300.1% YoY), and the FY2025 full-year result was -$248.7 million, down 197.15% from the prior year.
  • Net Cash Flow climbed to $55.0 million in Q2 2026 per PODD's latest filing, from -$233.8 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $325.9 million in Q1 2025 and bottomed at -$362.3 million in Q3 2025.
  • Historically, Net Cash Flow has averaged -$15.1 million across 5 years, with a median of $17.3 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Net Cash Flow soared 1238.89% in 2023, then tumbled 569.91% in 2025.
  • Over 5 years, Net Cash Flow stood at -$52.2 million in 2022, then soared by 130.27% to $15.8 million in 2023, then jumped by 271.52% to $58.7 million in 2024, then tumbled by 171.55% to -$42.0 million in 2025, then jumped by 230.95% to $55.0 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered $55.0 million, -$233.8 million, and -$42.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Abbott Laboratories 180.55 Bn 174.95 Bn 7.27 Bn -1.70 Bn
2 Intuitive Surgical 127.52 Bn 122.30 Bn 1.96 Bn 746.50 Mn
3 Medtronic 117.07 Bn 108.26 Bn 6.34 Bn -169.00 Mn
4 Stryker 103.72 Bn 100.25 Bn 4.50 Bn 527.00 Mn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn -892.00 Mn
6 Edwards Lifesciences 49.71 Bn 45.45 Bn 1.35 Bn 458.40 Mn
7 Alcon 33.00 Bn 31.55 Bn 1.68 Bn -222.00 Mn
8 Dexcom 32.13 Bn 30.18 Bn 830.00 Mn -8.30 Mn
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn 45.10 Mn
10 Insulet 9.31 Bn 8.77 Bn 562.60 Mn 55.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.00 Mn
Mar 31, 2026 -233.80 Mn
Dec 31, 2025 -42.00 Mn
Sep 30, 2025 -362.30 Mn
Jun 30, 2025 -170.30 Mn
Mar 31, 2025 325.90 Mn
Dec 31, 2024 58.70 Mn
Sep 30, 2024 77.10 Mn
Jun 30, 2024 70.70 Mn
Mar 31, 2024 49.50 Mn
Dec 31, 2023 15.80 Mn
Sep 30, 2023 26.50 Mn
Jun 30, 2023 24.10 Mn
Mar 31, 2023 -53.70 Mn
Dec 31, 2022 -52.20 Mn
Sep 30, 2022 18.90 Mn
Jun 30, 2022 1.80 Mn
Mar 31, 2022 -80.90 Mn
Dec 31, 2021 -63.40 Mn
Sep 30, 2021 4.20 Mn